More than half of community-dwelling individuals sixty years and older express concern about declining cognitive abilities. The current study’s aim was to evaluate hyperbaric oxygen therapy (HBOT) effect on cognitive functions in healthy aging adults. A randomized controlled clinical trial randomized 63 healthy adults (>64) either to HBOT(n=33) or control arms(n=30) for three months. Primary endpoint included the general cognitive function measured post intervention/control. Cerebral blood flow (CBF) was evaluated by perfusion magnetic resonance imaging.
About Dr. Erich LieberknechtThis author has not yet filled in any details.
So far Dr. Erich Lieberknecht has created 10 blog entries.
Scientists claim to have successfully reversed the biological aging process in a group of elderly adults. In a first of a kind study, researchers from Tel Aviv University and the Shamir Medical Center used a form of oxygen therapy to reverse two key indicators of biological ageing: Telomere length and senescent cells accumulation.
In the liver, most studies positively evaluated HBOT as a potential therapeutic option for liver transplantation, acute liver injury, nonalcoholic steatohepatitis, fibrosis and cancer.
These results suggest that exercise training with intermittent hyperbaric exposure represents a beneficial strategy for increasing endurance performance by facilitating oxidative and glycolytic capacities and the expression of proteins involved in mitochondrial biogenesis in the hindlimb muscles.
Our objective was to assess the safety and tolerability of hyperbaric oxygen therapy (HBO) as an adjunct to IVF therapy in women with a poor prognosis for pregnancy in a prospective observational pilot study. We conclude that HBO is well tolerated by women undergoing IVF treatment and that further study is required to determine whether this is an efficacious adjuvant therapy for women being treated by IVF. (Fertil Steril2005;83:226–8. ©2005 by American Society for Reproductive Medicine.)
Triple-negative breast cancer (TNBC) is more aggressive and metastatic than other breast cancer types. Cytotoxic chemotherapy is presently the predominant systemic therapy for TNBC patients. This case report highlights the influence of metabolically supported chemotherapy (MSCT), ketogenic diet (KD), hyperthermia (HT), and hyperbaric oxygen therapy (HBOT) in an overweight 29-year-old woman with stage IV (T4N3M1) triple-negative invasive ductal carcinoma of the breast.
A 9-week treatment of low-pressure hyperbaric oxygen therapy (40 sessions) in a patient with Alzheimer's Dementia caused a significant increase in global metabolism on 18FDG PET imaging with concomitant symptomatic improvement. Mild symptomatic regressionwas treated with intermittent HBOT, normobaric oxygen, and medications to stabilize symptoms, suggesting the possibility of long-term HBOT treatment of AD with pharmacotherapy.
The benefits of treating toxic exposure patients with Hyperbaric Therapy appear to be very positive. Initial results indicate that Hyperbaric Therapy has a demonstrable and positive effect on some symptoms such as short term memory loss and balance.
Patients with visual loss secondary to Age Related Macular Degeneration (AMD) underwent hyperbaric oxygen therapy and achieved improvements in their visual acuity and/or visual eld in cases considered untreatable by presently accepted methods.
Clinical studies have shown hyperbaric oxygen therapy to be effective in treating symptoms of fibromyalgia.